Skip to content

Safety and efficacy assessment of products on skin.

To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of skin glow, hydration, & skin even tone and on healthy female subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109061
Enrollment
36
Registered
2026-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Brightening Serum: Product is applied on the whole face twice a day for the period of 28 days Control Intervention1: Nil: NA

Sponsors

Aesthex Labs Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Indian / Asian female subjects. Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup). Having wheatish to dark complexion Between 18 and 44 years of age. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar .).

Exclusion criteria

Exclusion criteria: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months Having refused to give her assent by signing the consent form Taking part in another study liable to interfere with this study Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) Having a progressive asthma (either under treatment or last fit in the last 2 years) Being epileptic Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) Having cutaneous hypersensitivity Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

Design outcomes

Primary

MeasureTime frame
Skin glow, hydration, & skin even tone effectTimepoint: Baseline, Day 14, Day 28

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026